XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 78,157 $ 55,499
Marketable securities, current 136,397 189,405
Accounts receivable 2,158 3,102
Prepaid expenses and other current assets 8,017 9,761
Total current assets 224,729 257,767
Marketable securities, non-current 8,419 22,359
Property and equipment, net 5,540 5,842
Right-of-use asset 54,218 57,536
Restricted cash 3,443 3,443
Other assets 178 2,655
Total assets 296,527 349,602
Current liabilities:    
Accounts payable 2,216 1,328
Accrued expenses and other current liabilities 13,554 19,363
Deferred revenue, current 22,620 18,712
Operating lease liability, current 6,066 5,774
Total current liabilities 44,456 45,177
Deferred revenue, net of current 21,150 28,457
Operating lease liability, net of current 56,857 59,982
Total liabilities 122,463 133,616
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of June 30, 2025 and December 31, 2024, respectively 0 0
Common stock, par value of $0.0001 per share; 300,000,000 and 150,000,000 shares authorized as of June 30, 2025, and December 31, 2024, respectively, and 71,007,083 and 70,625,899 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 7 7
Additional paid-in capital 860,128 849,625
Accumulated other comprehensive income (loss) (30) 53
Accumulated deficit (686,041) (633,699)
Total stockholders’ equity 174,064 215,986
Total liabilities and stockholders’ equity $ 296,527 $ 349,602
Common stock, shares authorized (in shares) 300,000,000 150,000,000